The AIM-HI Accelerator Fund (AIM-HI) just announced 6 Semi-Finalists for the 2022 AIM-HI Women’s Venture…
It’s 2020, and still only 2.2% of all venture capital dollars go to companies led by women entrepreneurs in life sciences.
Let’s change that!
Join us on Thursday, September 24, at the AIM-HI Women’s Venture Competition Award Ceremony as we celebrate 8 leading-edge women entrepreneurs, each on the cusp of developing innovative therapies and diagnostics for all cancer types. The AIM-HI Accelerator Fund Women’s Venture Competition is a first-of-its-kind initiative that provides funding, coaching and networking opportunities to women-led oncology start-ups.
Make sure you don’t miss the excitement as we announce the top two finalists from our pool of 8 amazing semi-finalists. It is sure to be game-changing for the participating women-led oncology technology businesses, as well as the future of cancer research. The winner will receive an equity investment of $300,000 from AIM-HI as seed money for proof of concept and proof of value on the path to clinical trials and, eventually, to new effective therapeutics and diagnostics that could save patients’ lives.
REGISTER NOW for this FREE fun event and hear all about these aspiring female scientist-entrepreneurs in the oncology arena.
Ready to do more? AIM-HI has the resources to fund only one of the finalists. But we’d like to support both! DONATE NOW and help us raise an additional $300,000 to fund both finalists and double the impact for women entrepreneur-scientists who are creating life-saving oncology innovations!
Please join us on September 24! Invite your network and, together, we can all cheer on these inspiring women scientist-entrepreneurs!